4 March 2021 - Future vaccine modifications that respond to new variants of coronavirus to be made available quickly to UK recipients, without compromising on safety, ...
1 March 2021 - Rare Disease Day is a time to reflect on both the progress that has been made, and ...
25 February 2021 - EMA has issued guidance outlining the requirements for manufacturers planning to modify their COVID-19 vaccines in ...
8 February 2021 - As the Food and Drug Administration moves closer to a decision about whether to approve a ...
2 February 2021 - The European Medicines Agency has released a draft guidance to assist drug developers using its Priority ...
12 January 2021 - Today, the U.S. FDA released the agency’s first artificial intelligence/machine learning-based software as a Medical Device Action ...
8 December 2020 - The Oxford-AstraZeneca effort held great promise to help arrest the pandemic. But a series of miscues caused ...
23 November 2020 - On Monday, 30 November, EMA is hosting a workshop to discuss the benefits and impact of ...
21 November 2020 - The furious race to develop a coronavirus vaccine played out against a presidential election, between a pharmaceutical ...
21 October 2020 - Early deal with Merck was scotched for fear poor countries would be left out; now university could ...
15 October 2020 - On Thursday, 29 October, EMA is hosting a symposium to discuss new approaches to facilitating and ...
8 October 2020 - US drug prices are the highest in the world and are continuing to rise, with an increasing ...
2 October 2020 - The BIO trade group, whose members include most of the vaccine makers, asked the health secretary to ...
30 September 2020 - Albert Bourla, 58, is chairman and chief executive of Pfizer, a multinational pharmaceutical company. Bourla is a ...
24 September 2020 - A group of pharmaceutical giants, biotech companies, industry peak bodies and the CSIRO have banded together ...